120 related articles for article (PubMed ID: 27330795)
1. Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe.
Yuan J; Lei M; Yang Z; Fu J; Huo L; Hong J
Mol Clin Oncol; 2016 Jul; 5(1):181-188. PubMed ID: 27330795
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated stereotactic radiotherapy for brain metastases: a dosimetric and treatment efficiency comparison between volumetric modulated arc therapy and intensity modulated radiotherapy.
Ma Y; Li M; Yin Y; Kong L; Sun X; Lin X; Yu J
Technol Cancer Res Treat; 2010 Oct; 9(5):499-507. PubMed ID: 20815421
[TBL] [Abstract][Full Text] [Related]
3. Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer.
Vieillot S; Azria D; Lemanski C; Moscardo CL; Gourgou S; Dubois JB; Aillères N; Fenoglietto P
Radiat Oncol; 2010 Oct; 5():92. PubMed ID: 20942958
[TBL] [Abstract][Full Text] [Related]
4. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
[TBL] [Abstract][Full Text] [Related]
5. 3D-conformal RT, fixed-field IMRT and RapidArc, which one is better for esophageal carcinoma treated with elective nodal irradiation.
Wang D; Yang Y; Zhu J; Li B; Chen J; Yin Y
Technol Cancer Res Treat; 2011 Oct; 10(5):487-94. PubMed ID: 21895033
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma.
Martin S; Chen JZ; Rashid Dar A; Yartsev S
Radiother Oncol; 2011 Dec; 101(3):431-7. PubMed ID: 21962823
[TBL] [Abstract][Full Text] [Related]
7. SU-E-T-591: Volumetric-Modulated Arc Radiotherapy for Carcinomas of the Pituitary Adenomas: A Treatment Planning Comparison with Fixed Field IMRT.
Sun T; Liu T; Yin Y
Med Phys; 2012 Jun; 39(6Part19):3841-3842. PubMed ID: 28517077
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison of RapidArc with fixed gantry intensity-modulated radiotherapy treatment for multiple liver metastases radiotherapy.
Yin Y; Ma C; Gao M; Chen J; Ma Y; Liu T; Lu J; Yu J
Med Dosim; 2011; 36(4):448-54. PubMed ID: 21474299
[TBL] [Abstract][Full Text] [Related]
9. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT.
Clivio A; Fogliata A; Franzetti-Pellanda A; Nicolini G; Vanetti E; Wyttenbach R; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):118-24. PubMed ID: 19181409
[TBL] [Abstract][Full Text] [Related]
10. [Dosimetric analysis of volumetric modulated arc therapy and intensity modulated radiotherapy for patients undergone breast-conserving operation].
Sun HT; Yang RJ; Jiang P; Jiang WJ; Li JN; Meng N; Wang JJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):188-192. PubMed ID: 29483745
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT).
Rapole PS; Karunanithi G; Kandasamy S; Prabhu S; Kumar R; Vivekanandam S
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2499-2506. PubMed ID: 30256043
[TBL] [Abstract][Full Text] [Related]
12. SU-E-T-585: Application of IMAT in Non-Small-Cell Lung Cancer with Simultaneously Integrated Boost Radiation Therapy.
Liu T; Yin Y; Gong G; Zhang G; Zhai D
Med Phys; 2012 Jun; 39(6Part19):3840. PubMed ID: 28517068
[TBL] [Abstract][Full Text] [Related]
13. Comparison of dose distributions hippocampus in high grade gliomas irradiation with linac-based imrt and volumetric arc therapy: a dosimetric study.
Canyilmaz E; Uslu GD; Colak F; Hazeral B; Haciislamoglu E; Zengin AY; Sari A; Yoney A
Springerplus; 2015; 4():114. PubMed ID: 25815244
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer planning: Complex conformal vs modulated therapies.
Chapman KL; Witek ME; Chen H; Showalter TN; Bar-Ad V; Harrison AS
Med Dosim; 2016; 41(2):100-4. PubMed ID: 26831922
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A
Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261
[TBL] [Abstract][Full Text] [Related]
17. The effect of the target-organ geometric complexity on the choice of delivery between RapidArc and sliding-window IMRT for nasopharyngeal carcinoma.
Kan MW; Leung LH; Yu PK
Med Dosim; 2013; 38(3):337-43. PubMed ID: 23642300
[TBL] [Abstract][Full Text] [Related]
18. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.
Cozzi L; Dinshaw KA; Shrivastava SK; Mahantshetty U; Engineer R; Deshpande DD; Jamema SV; Vanetti E; Clivio A; Nicolini G; Fogliata A
Radiother Oncol; 2008 Nov; 89(2):180-91. PubMed ID: 18692929
[TBL] [Abstract][Full Text] [Related]
19. Poster - Thur Eve - 66: A planning comparison between RapidArc and intensity modulated radiotherapy for head and neck cancer.
Jiang R; Fleck A; Schaly B; Charland P; Zhan L; Alliet K; Rachakonda R; Osei E
Med Phys; 2012 Jul; 39(7Part4):4637. PubMed ID: 28516640
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Multiple Treatment Planning Techniques for High-Grade Glioma Tumors Near to Critical Organs.
Bas Ayata H; Ceylan C; Kılıç A; Güden M; Engin K
Oncol Res Treat; 2018; 41(9):514-519. PubMed ID: 30086547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
